Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
J Med Invest ; 71(1.2): 121-128, 2024.
Article in English | MEDLINE | ID: mdl-38735707

ABSTRACT

OBJECTIVES: Partially hydrolyzed guar gum (PHGG) is a soluble dietary fiber;in addition to improving bowel movements, it maintains intestinal health by producing short-chain fatty acids. However, majority of clinical studies on PHGG have been concluded within a month and excluded usual drug therapy. Hence, this study aimed to determine the effects of long-term consumption of PHGG, in combination with drug therapy, on gut bacteria ratios, laboratory values for inflammatory response, and fecal characteristics. METHODS AND RESULTS: The study was performed in patients with irritable bowel syndrome (IBS), Crohn's disease (CD), and ulcerative colitis (UC), by the administration of PHGG for six months while they continued their usual treatment. PHGG treatment caused significant changes in patients with IBS, including an increase in the abundance of short-chain fatty acid-producing bacteria, a significant decrease in Bacteroides abundance, and normalization of the Bristol scale of stool. In patients with UC, non-significant normalization of soft stools and decrease in fecal calprotectin were observed. Adverse events were not observed in any of the groups. CONCLUSION: Thus, it would be beneficial to include PHGG in the usual drug therapies of patients with IBS. J. Med. Invest. 71 : 121-128, February, 2024.


Subject(s)
Dietary Fiber , Galactans , Gastrointestinal Microbiome , Irritable Bowel Syndrome , Mannans , Plant Gums , Humans , Gastrointestinal Microbiome/drug effects , Irritable Bowel Syndrome/drug therapy , Irritable Bowel Syndrome/microbiology , Male , Female , Dietary Fiber/administration & dosage , Adult , Middle Aged , Mannans/administration & dosage , Plant Gums/administration & dosage , Galactans/administration & dosage , Inflammatory Bowel Diseases/drug therapy , Feces/microbiology , Feces/chemistry , Fatty Acids, Volatile/analysis , Fatty Acids, Volatile/metabolism
2.
Yakugaku Zasshi ; 134(2): 203-11, 2014.
Article in Japanese | MEDLINE | ID: mdl-24492224

ABSTRACT

Global spread of counterfeit medicines is an imminent threat for the patients' safety. Although major targets of counterfeits are still erectile dysfunction (ED) drugs in the industrialized countries, including Japan, anti-cancer agents and some medicines for metabolic syndromes are also being counterfeited and circulated to the market mainly through the Internet. Due to the global expansion of the business, pharmaceutical companies based in Japan are suffering from the damage of counterfeits, illegal sales including diversion, and thefts, which have never been experienced in the conventional domestic market. We, pharmaceutical companies, must be responsible for the prevention of the prevalence because our mission is to deliver effective and safe medicine to patients. For this end, we are taking necessary actions including, 1. Forestalling counterfeit, falsification and illicit trade: Measures to prevent counterfeiting are taken by introducing anti-counterfeit technologies to the packaging and tablets on a risk basis. It is also important to establish supply chain security on a global scale. 2. Finding out counterfeits and cooperating crackdown: We are conducting market and internet surveillances when high risk products are sold in high risk markets. The outcome of the criminal investigation is reported to authorities and police if necessary. 3. Conducting educational campaign to medical staff or patients: For example, four companies which manufacture and sell ED drug in Japan are collaboratively continuing activities to raise the awareness of the danger of Internet purchase. To deliver effective and safe medicines stably and globally, pharmaceutical companies extend comprehensive measures against counterfeit and illicit trading.


Subject(s)
Counterfeit Drugs , Crime/prevention & control , Drug Industry , Drug and Narcotic Control/legislation & jurisprudence , Patient Safety , Global Health , Humans , Internet , Japan
3.
Cell Transplant ; 21(2-3): 421-8, 2012.
Article in English | MEDLINE | ID: mdl-22793049

ABSTRACT

Hybrid artificial liver (HAL) is an extracorporeal circulation system comprised of a bioreactor containing immobilized functional liver cells. It is expected to not only serve as a temporary liver function support system, but also to accelerate liver regeneration in recovery from hepatic failure. One of the most difficult problems in developing a hybrid artificial liver is obtaining an adequate cell source. In this study, we attempt to differentiate embryonic stem (ES) cells by hepatic lineage using a polyurethane foam (PUF)/spheroid culture in which the cultured cells spontaneously form spherical multicellular aggregates (spheroids) in the pores of the PUF. We also demonstrate the feasibility of the PUF-HAL system by comparing ES cells to primary hepatocytes in in vitro and ex vivo experiments. Mouse ES cells formed multicellular spheroids in the pores of PUF. ES cells expressed liver-specific functions (ammonia removal and albumin secretion) after treatment with the differentiation-promoting agent, sodium butyrate (SB). We designed a PUF-HAL module comprised of a cylindrical PUF block with many medium-flow capillaries for hepatic differentiation of ES cells. The PUF-HAL module cells expressed ammonia removal and albumin secretion functions after 2 weeks of SB culture. Because of high proliferative activity of ES cells and high cell density, the maximum expression level of albumin secretion function per unit volume of module was comparable to that seen in primary mouse hepatocyte culture. In the animal experiments with rats, the PUF-HAL differentiating ES cells appeared to partially contribute to recovery from liver failure. This outcome indicates that the PUF module containing differentiating ES cells may be a useful biocomponent of a hybrid artificial liver support system.


Subject(s)
Cell Culture Techniques/methods , Embryonic Stem Cells/cytology , Hepatocytes/cytology , Liver, Artificial , Spheroids, Cellular/cytology , Ammonia/metabolism , Animals , Butyrates/pharmacology , Cell Aggregation/drug effects , Cell Culture Techniques/instrumentation , Cell Differentiation/drug effects , Hepatocytes/metabolism , Mice , Mice, Inbred C57BL , Polyurethanes/chemistry , Serum Albumin/metabolism , Spheroids, Cellular/pathology
4.
J Colloid Interface Sci ; 336(2): 879-88, 2009 Aug 15.
Article in English | MEDLINE | ID: mdl-19476950

ABSTRACT

FePt alloy in a bulk state is well known as a magnetic material. FePt nanoparticles, which are protected by poly(N-vinyl-2-pyrrolidone) (PVP) and have a face-centered tetragonal (fct) structure at a size of a few nanometers in diameter, have been directly synthesized by a polyol process in high-boiling point tetraethylene glycol used as a reducing reagent for the reduction of Fe(III) acetylacetonate and Pt(II) acetylacetonate. Their magnetic properties (coercivity and saturation magnetization) were dependent on the size and made progress as their diameters increased. The size in diameter was easily controlled by altering the content of PVP, the time for refluxing, and reaction temperature. FePt nanoparticles showed diameter-dependent coercivities at room temperature and they abruptly increased at over 4 nm in diameter. Ferromagnetic FePt nanoparticles with an fct structure were also synthesized at relatively low reaction temperature without refluxing. Likewise, as-synthesized FePt nanoparticles prepared by refluxing at 251 degrees C for 3 h displayed the fct structure and clearly indicated the ferromagnetism at room temperature. Reaction kinetics such as long refluxing time and slow temperature elevation rate were found to be important key factors to synthesize the ferromagnetic FePt nanoparticles although the reaction temperature was very critical as well.

5.
J Biosci Bioeng ; 105(4): 350-4, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18499050

ABSTRACT

Embryonic stem (ES) cells are a type of pluripotent stem cell line isolated from the inner cell mass of blastocysts and characterized by an almost unlimited self-renewal capacity and differentiation potential in vitro into multiple cell lineages. Therefore the use of ES cells has recently received much attention as a novel cell source for various hybrid artificial organs. To use ES cells, it is necessary to be able to produce functional matured cells from ES cells in large quantities. In this study, we applied polyurethane foam (PUF)/spheroid culture, which enables spontaneous spheroid formation and mass cultivation of cultured cells, to mouse ES cells for hepatic differentiation. Mouse ES cells spontaneously formed spherical multicellular aggregates (spheroids) in the pores of the PUF within 1 d. To induce hepatic differentiation, specific growth factors were added to the culture medium. Mouse ES cells proliferated by day 20, and high cell density (about 1.0 x 10(8) cells/cm(3)-PUF) was achieved. Differentiating ES cells expressed endodermal-specific genes, such as alpha-fetoprotein, albumin and tryptophan 2,3-dioxygenase. The activity of ammonia removal of mouse ES cells per unit volume of the module was detected by day 21 and increased with culture time. Maximum expression levels were comparable to those of primary mouse hepatocytes. Mouse ES cells could express liver-specific functions at high level because of the high cell density culture and hepatic differentiation. These results suggest that the PUF/spheroid culture method could be useful to develop mass differentiation cultures.


Subject(s)
Cell Differentiation/physiology , Cell Proliferation , Embryonic Stem Cells/physiology , Liver/physiology , Pluripotent Stem Cells/physiology , Polyurethanes , Animals , Antigens, Differentiation/biosynthesis , Cell Culture Techniques/methods , Embryonic Stem Cells/cytology , Liver/cytology , Mice , Organ Specificity/physiology , Pluripotent Stem Cells/cytology , Spheroids, Cellular/cytology , Spheroids, Cellular/physiology , Time Factors
6.
J Colloid Interface Sci ; 308(2): 564-7, 2007 Apr 15.
Article in English | MEDLINE | ID: mdl-17289069

ABSTRACT

Direct synthesis of fct-structured FePt nanoparticles was successfully achieved by using poly(N-vinyl-2-pyrrolidone) as a protective reagent at lower temperature than the case using low molecular weight ligands as a protective reagent. Experimental data suggest that a transformation of FePt nanoparticles from face-centered cubic to face-centered tetragonal (fct) structure takes place at reaction temperature of 261 degrees C. The results of XRD and the magnetic properties exhibit that the FePt nanoparticles synthesized at 261 degrees C have partially ordered fct-structure and a ferromagnetic behavior at room temperature.

7.
Dig Dis Sci ; 50(10): 1823-8, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16187181

ABSTRACT

We evaluated the changes in the levels of released cytokines following heat preconditioning of the livers used in rat liver transplantation. The donor rats in the heat preconditioning (HP) group were subjected to heat preconditioning 48 h before graft harvesting. The liver isografts were preserved in Euro-Collins solution for 8 h, and then transplanted orthotopically. The one-week survival rate of the HP group was significantly better than that of the control (C) group. The serum levels of interleukin-6 and interleukin-10 were significantly lower in the HP group than in the C group. Histological staining revealed that the stagnation of red blood cells and infiltration of neutrocytes were reduced in the HP group. The expression of intercellular adhesion molecule-1 was decreased around the central vein in the HP group, as revealed by immunohistochemistry. These results indicate that heat preconditioning downregulates cytokine release and reduces the frequency of microcirculation disorders.


Subject(s)
Hyperthermia, Induced , Interleukin-10/blood , Interleukin-6/blood , Liver/metabolism , Tissue and Organ Harvesting/methods , Tumor Necrosis Factor-alpha/metabolism , Animals , Graft Survival , Intercellular Adhesion Molecule-1/metabolism , Liver/pathology , Liver Transplantation , Male , Rats , Rats, Inbred Lew
SELECTION OF CITATIONS
SEARCH DETAIL
...